Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push…
International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years,…
“60 Minutes” correspondent Scott Pelley paid tribute Sunday to Bill Owens, the show’s executive producer who resigned last week, saying…
If President Donald Trump’s 145% levy against imports from China holds, Hasbro estimates it could see as much as a $300…
U.S. spirit exports reached a record $2.4 billion in 2024, driven in large part by tariff concerns and ongoing…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
OKLAHOMA CITY — Amazon and Nvidia executives said Thursday that the construction of artificial intelligence data centers is not…
The top producer at CBS’ “60 Minutes” announced Tuesday he would step down from the newsmagazine because he had…
LOS ANGELES — A group of California homeowners is taking on insurance companies that they say illegally coordinated to…